Jura Health

Denver, CO — Jura Health, an Innosphere Ventures client company committed to health equity for rare disease patients and their families, is pleased to announce that Samba Scientific has made a strategic investment in the company. Samba Scientific, a leading scientific marketing company, with expertise in demand creation for growth-stage companies, will help Jura reach more patients with low or no-cost access to rare disease testing and crucial guidance for next steps.

On average, it takes 6 years to get an accurate diagnosis for someone suspected of having a rare disease.  During this time, a patient will typically see more than 16 physicians with an average cost of $220,000 to find the diagnosis. This doesn’t have to be the case.

Jura Health dramatically shortens the lengthy diagnostic journey and reduces costs by providing at-home DNA sample collection, whole genome sequencing, and genetic counseling, delivering results in weeks rather than years. Covered by Medicaid in Colorado, the saliva-based test is accessible at no cost to Medicaid patients, including counseling and follow-up support, providing much-needed convenience and speed for rare disease patients.

Read the full article on innosphereventures.com

Share this page on social